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Class I molecules of the MHC are polymorphic cell surface glycoproteins that 
appear to mediate interactions between CTL and their target cells (1). They are 
heterodimers  consisting of a  43,000-D,  MHC-encoded heavy chain,  noncova- 
lently associated with a  12,000-D light chain, O~-microglobulin (2). This complex 
is anchored in the membrane via a stretch of hydrophobic amino acids near the 
carboxyl terminus of the heavy chain, and as such has properties typical of many 
integral membrane glycoproteins. 
Class I genes are comprised of eight exons, which correlate well with structural 
and functional domains of the molecule (3). Exon  1 encodes the signal peptide, 
exons 2-4 encode three extracellular  domains,  exon 5 encodes the transmem- 
brane region, and exons 6, 7, and (in most cases) 8 encode a small, intracellular 
tail. 
Previous studies of a mutagenized B lymphoblastoid cell line have identified a 
clone, 8.14.1, which secretes a water soluble form of the HLA-A2 antigen (4, 5). 
Characterization  of the  secreted  polypeptide,  and  ultimately,  the  analysis  of 
cDNA clones from both the parent and mutant cell lines, indicate that secretion 
results  from  an  unusual  pattern  of RNA  splicing  that  excludes  exon  5  from 
mature,  HLA-A2-encoding transcripts (6). Instead, exon 4 is joined directly to 
exon 6, with the correct reading frame maintained.  A  transcript  spliced in this 
fashion would be expected to encode a  polypeptide that  lacks 39 amino acids, 
including the hydrophobic amino acids that would normally anchor the polypep- 
tide in the plasma membrane.  However, the polypeptide would retain a normal 
carboxyl terminus. 
Although class I molecules are best understood in terms of both structure and 
function as cell surface integral membrane glycoproteins, there have been reports 
of soluble  forms  of these  molecules.  For  example,  HLA-A  and  -B  antigenic 
determinants  have been detected in  high  speed supernatants  of human  serum 
(reviewed in reference 7). Emerson et al. showed that H-2K  k is shed in association 
with membrane lipids from murine spleen cells (8).  Most recently, a gene in the 
Qa region  of the murine  MHC has been shown to encode a  truncated  class  I 
molecule that is synthesized in the liver and is detectable in the serum (9-I 2). 
The  example  of mutant  8.14.1  has  suggested  a  potential  mechanism  for 
generating  stable, water soluble, secreted forms of HLA-A and -B antigens  in 
vivo. Using mutant  8.14.1  and its parent cell line T5-1  as a  model system, the 
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present  study  was  conducted  to  assess  whether  a  similar  splicing  mechanism 
might  be  operative  in  generating  secreted  HLA-A  and  -B  locus  products  in 
nonmutagenized human cells. T  and B cell lines, a hepatoma cell line, and normal 
PBL are examined. 
Materials and Methods 
Cells  and Cell Culture.  B lymphoblastoid cell lines used were: T5-1  (HLA-AI, -A2, 
-B8, -B27) and its immunoselected mutant 8.14.1, WT51 (HLA-A9, -B14), MST (HLA- 
A3,-B7), JY (HLA-A2,-BT), SB (HLA-A1,-A2, -B12,-Bwl 7), AS (HLA-A2,-A24,-B27), 
and 23.1 (HLA-A2, -B27). T  leukemic cell lines used were: HPB-ALL (HLA-A24, -B15, 
-Bw51), HPB-MLT (HLA-A24,-Aw33,-Bwl5), MOLT-3 (HLA-A1, -A10), 8402 (HLA- 
A1, -A29), CEM (HLA-A1, -Aw30, -B8, Bw40), and HSB (HLA-AI, -A2, -B12, -Bwl 7). 
The  hepatoma  cell  line  used  was  HEP-G2  (HLA-A2,  -A9,  -B5,  -Bwl7).  Cells  were 
maintained  in  either  RPMI  1640  or  DME  (Gibco  Laboratories,  Grand  Island,  NY), 
supplemented with either 10 or 15% FCS,  100 U]ml penicillin, and 100 t~g]ml strepto- 
mycin. PBL were obtained from donors M.B. (HLA-A1, -A24, -B18, -Bw44), J.C. HLA- 
A2, -A23, -B27, -Bw44), and M.L. (HLA-A2, -A11, -B7, -Bw35) by centrifugation through 
Lymphocyte Separation Medium (Litton Bionetics, Kensington, MD).  3-d PHA- (Difco 
Laboratories Inc., Detroit, MI) stimulated cultures were harvested for metabolic labeling. 
Metabolic Labeling,  Preparation  of Cell Lysates,  and  Culture  Supernatants.  Cells  were 
preincubated for 45 min in methione-free RPMI  1640 or DME supplemented with 10% 
FCS at a density of 2 ×  106/mi, and were then labeled in this same medium supplemented 
with 250 uCi/ml [sSS]methionine (1,000 Ci/mmol, New England Nuclear, Boston, MA) 
for a period of 4-14 h. After labeling, cells were harvested by centrifugation for 5 rain at 
1,000 g. Cells were washed once in PBS, and were lysed at 4 ×  106]ml in the presence of 
2% NP-40 (Particle Data,  Inc., Elmhurst,  IL),  0.5 mM  DTT, 0.1  mM PMSF,  10 mM 
Tris-HCI (pH 7.5). After 0.5-1 h on ice, iysates were cleared by centrifugation at 13,000 
g for 15 min in an Eppendorf microfuge. Labeling supernatants were cleared in similar 
fashion, and these low speed supernatants were usually centrifuged for an additional 1 h 
at 100,000 g using a 50Ti rotor (Beckman Instruments, Inc., Paio Alto, CA) in either a 
Beckman L5-65 or Sorvail OTD-65 ultracentrifuge (Du Pont de Nemours, E.I. & Co. 
Inc./Sorvall  Instruments  Div.,  Newton,  CT).  Lysates and  culture  supernatants  were 
routinely stored at -70 ° C. 
Antibodies  and  Immunoprecipitation.  mAbs  used  were:  W6/32  (HLA-A-,  -B-,  -C- 
specific; reference 13); 4E (HLA-B-, -C-specific; reference 14); PA2.1 (HLA-A2-specific; 
reference  15);  and  187.1  (mouse  kappa  chain-specific, a  gift from  Dr.  Brett  Spear, 
University of Pennsylvania, Philadelphia, PA).  Aliquots of lysate and supernatant were 
precleared by incubation with normal rabbit serum plus an excess of Staphylococcus  aureus 
immunoadsorbent (Pansorbin; Calbiochem-Behring, La Jolla, CA) for 2 h on ice. Protein 
A Sepharose (Pharmacia Fine Chemicals, Piscataway, N  J) was then used as the immunoad- 
sorbant  for  both  the  control  and  specific antibody  imrnunoprecipitations  presented. 
Conditions for washing immunoprecipitates were as described (16), except that only three 
high salt and one low salt washes were performed. 
Gel Electrophoresis.  Analyses of polypeptides by discontinuous SDS-PAGE and by two- 
dimensional gel  electrophoresis were as  described previously (5,  17,  18).  Radioactive 
species were detected by fluorography (! 9), and quantitation of fluorographic or autora- 
diographic  images  was  performed using  a  Quick  Scan  R  +  D  densitometer (Helena 
Laboratories, Beaumont, TX). 
Detergent Binding and Proteolytic Digestion  Analyses.  Precondensed Triton X- 114 (TX- 
114; ~ Fluka, Hauppauge, NY) was a generous gift from Dr. Carolyn Doyle, Cold Spring 
Harbor Laboratory, Cold Spring Harbor, NY. TX-114 was used in place of NP-40 for 
cell lysis, and was added to culture supernatant preparations at  1% final concentration. 
Condensation and phase separation were performed as described by Bordier (20). Prote- 
l Abbreviation used in this paper:  TX-114, Triton X-114. KRANGEL  1175 
olysis  with both  papain  and Pseudomonas fragi  protease  was  performed  essentially as 
described previously (5). However, papain digestion of TX-114 solubilized cell extracts 
was performed at 14°C for 3 h to avoid condensation during the incubation. 
Ultracentrifugal Analyses.  Ultracentrifugal flotation was based upon the conditions of 
Allison et al. (21). Briefly, solid KBr was added to 1-ml aliquots of a culture supernatant 
preparation to bring their densities to either  1.06  or 1.21 g/ml. 0.65-ml aliquots were 
then centrifuged for 44 h at 43,000 rpm in 5 × 41-mm ultraclear centrifuge tubes, using 
an AH650 rotor with appropriate adaptors in a  model OTD 65B ultracentrifuge (Du 
Pont de Nemours, E.I. & Co. Inc./Sorvall Instruments Div.). Three 0.2-ml fractions were 
harvested by pipetting from the top of the tube. These were diluted up to 1 ml with the 
addition of 10 mM Tris-HCl (pH 8.0), after which immunoprecipitation was performed 
as usual.  Sucrose density gradient centrifugation was performed using a  12-ml  5-20% 
gradient of sucrose in 0.15  M NaCI,  5 mM EDTA, 0.2% azide, 50 mM Tris-HCl (pH 
7.5).  0.6 ml of culture supernatant preparation was mixed with ~SI-labeled  BSA (a gift 
from Dr. John Fraser, Dana Farber Cancer Institute) to be used as a marker, and was 
loaded onto the gradient. Centrifugation was for 20 h at 26,000 rpm using a model SW50 
rotor in a  model L5-65 centrifuge (Beckman Instruments Inc.). 0.7-ml fractions were 
collected  using  a  peristaltic  pump,  and  were  used  directly  for  immunoprecipitation 
analysis. In addition, small aliquots of each fraction were used to determine the distribution 
of 12~I radioactivity across the gradient. 
Purification and Analysis of RNA.  Enrichment for poly(A)-containing RNA, agarose 
gel electrophoresis, and blot hybridization analysis were carried out as described previously 
(6).  The A4/6  20mer and an  HLA-B7 cDNA  insert (22)  were used as probes  under 
conditions described previously (6). 
Identification and  Sequence Analysis of cDNA Clones.  A  lambda gtl0  cDNA  library 
constructed from HPB-MLT poly(A) +  RNA was kindly provided by Dr. Deno Dialynas, 
Harvard University, Cambridge, MA (Dialynas,  D.,  C. Murre, T.  Quertermous, J.  M. 
Boss, J. G. Seidman, and J. L. Strominger, manuscript submitted for publication). Plaque 
lifts were screened in duplicate, with the HLA-B7 cDNA and oligonucleotide A4/6 under 
conditions decribed previously (6).  Phage minipreps were essentially as described (23). 
Inserts were purified by electrophoresis through low melting-point agarose (Bethesda 
Research Laboratories, Gaithersburg, MD), subcloned into the Eco RI site of pBR322, 
and plasmid minipreps prepared (24).  Pvu II digested DNA was cloned into the Sma I 
site of M13  mplS, and was sequenced by the dideoxy chain termination method (25), 
using a 6% polyacrylamide gel with a buffer gradient (26). 
Results 
HLA-A and -B Antigens Are Detectable in Culture Supernatants  of a T Leukemic 
Cell Line.  The T  leukemic cell line HPB-ALL (HLA-A24, -B15, -Bw51; refer- 
ence 97) has been characterized in detail. Cells were metabolically labeled for 14 
h with [3~S]methionine, after which detergent lysates were prepared, and culture 
supernatants were harvested, as described in Materials and Methods. Immuno- 
precipitation was performed using the HLA-A-, -B-, -C-specific mAb W6/32, 
and immunoprecipitated polypeptides were resolved by SDS-PAGE and visual- 
ized by fluorography (Fig.  1A). Whereas polypeptides of 43,000 and 12,000  D 
are detected in the cell lysate, polypeptides of 39,000 and 12,000 D are detected 
in the culture supernatant. A similar experiment performed after labeling in the 
presence  of tunicamycin rules  out the  possibility that  the  unusual size  of the 
supernatant  localized  form  results  from  a  glycosylation difference  (data  not 
shown). Taking into account the difference in cell lysate and culture supernatant 
cell  equivalents  used  in  the  experiment  presented  in  Fig.  1A,  densitometric 
quantitation suggests that the 39,000-D  species is present at a  level ~2.5%  that 
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FIGURE  1.  Immunoprecipitation analysis of HPB-ALL cell lysates and culture supernatants. 
(A) Cell  ]ysate  and culture supernatant were  prepared  from  cells  labeled for  14  h  in the 
presence of [sSS]methionine. Cell lysate immunoprecipitations were from 0.2 times the cell 
equivalents used for the supernatant immunoprecipitations. The antibodies used were: lanes 
1 and 3, normal rabbit serum; lanes 2 and 4, W6/32. (B) Cell lysate and culture supernatant 
were prepared from cells labeled for 4.5 h in the presence of [sSS]methionine. lmmunoprecip- 
itation was  with  W6/32.  Lanes  1-4  are  serial  threefold  dilutions of immunoprecipitated 
material, representing 0.1,  0.03,  0.01,  and  0.003  times the  cell equivalents used  for  the 
supernatant immunoprecipitation (lane  5).  Densitometric  analysis indicates a  near  linear 
response in the intensity of the 43,000-D species  over the range covered by the dilutions in 
lanes 1-3. Analysis was by SDS-PAGE followed by fluorography, and only the relevant portion 
of the fluorograph is presented. 
varied from  1 to >5%,  with labeling times varying between 4  and  14 h.  In  the 
experiment depicted in Fig.  1 B, a 4.5-h labeling period reveals that polypeptides 
of-39,000  D can be detected in both the culture supernatant and the cell lysate. 
This cellular form is typically found in shorter labeling periods, and presumably 
represents  an  intracellular  precursor  to  the  supernatant  localized  form.  Most 
often, the total amount of extracellular and intracellular 39,000-D forms is -4% 
that of the 43,000-D  form. However in this particular experiment, the extracel- 
iular form represented  ~5%, and the intracellular form ~1 I%. The reason for 
this variability is not understood. 
Fig. 2 presents two-dimensional gel electrophoretic analysis of immunoprecip- KRANGEL  1177 
FmURE 2.  Two-dimensional  gel electrophoresis  of immunoprecipitates  from HPB-ALL  cell 
lysate and culture supernatant. Only  the relevant  portions of the fluorographs  are presented. 
Cell lysate  and culture supernatant  immunoprecipitations  are not quantitatively  related. The 
antibodies used were: W6132 (HLA-A-, -B-, -C-specific), A and C; and 4E (HLA-B-, -C- 
specific), B and D. Those spots immunoprecipitated  by W6/32 but not by 4E are presumed to 
represent HLA-A24. 
itated polypeptides. The 39,000-D polypeptides immunoprecipitated by W6/32 
from the HPB-ALL culture supernatant are clearly resolved into two series of 
spots (Fig. 2 C). Immunoprecipitation using an antibody specific for HLA-B and 
-C locus products (4E)  indicates that the less abundant spots represent HLA-B 
and/or -C locus products (Fig. 2D), whereas the more abundant spots represent 
A  locus products. Thus, both an HLA-A and an HLA-B (or -C) locus product 
are present in the HPB-ALL culture supernatant. The relative abundance of the 
two products has not been found to vary. 
The  Supernatant  Class  I  Molecules  Behave  As  Water  Soluble  Heterodimers. 
Culture  supernatant-localized class  I  molecules  could  potentially arise  by  a 
number  of distinct  mechanisms,  including proteolysis from  the  cell  surface, 
shedding in association with membrane lipid, and bona fide secretion of water 
soluble forms. The structure and characteristics of the supernatant molecules 
were studied to help distinguish among these possibilities. 
The solubility properties of the supernatant-localized molecules were investi- 
gated by assessing their interaction with the detergent TX- 114. At 4 ° C, a solution 
of TX-114  is  homogeneous,  whereas  at  37°C  this  solution  separates  into  a 1178  SECRETION  OF  HUMAN  CLASS  I  ANTIGENS 
FIGURE 3.  Detergent  binding properties of immunoprecipitated polypeptides.  HPB-ALL 
cells were labeled for 4 h in the presence of [sSS]methionine,  after which the culture supernatant 
was harvested and cell lysate was prepared using either TX-114 or NP-40 (A) Aliquots of TX- 
114 cell lysate were treated with increasing  amounts of papain, after which they were separated 
into detergent (D)  or aqueous (,4) phases.  Immunoprecipitation was then performed using 
W6/32, and immunoprecipitates were analyzed by SDS-PAGE followed by fluorography. (B) 
Aliquots of NP40 cell lysate were immunoprecipitated using either normal rabbit serum (lane 
1) or W6/32 (lane 2). An equivalent aliquot of TX-114 cell lysate was separated into aqueous 
(lane 3) and detergent (lane 4) phases, which were then immunoprecipitated using W6/32. 
Aliquots of culture supernatant were immunoprecipitated with either normal rabbit serum 
(lane 1 ) or W6/32 (lane 2). TX- 114 was added to an equivalent aliquot of culture supernatant, 
after which it was separated into aqueous (lane 7) and detergent (lane 8) phases, which were 
then immunoprecipitated using W6/32. Cell lysate immunoprecipitations  were from 0.1 times 
the cell equivalents used for culture supernatant immunoprecipitations. 
detergent phase and an aqueous phase.  Molecules that bind detergent, such as 
integral  membrane  proteins,  will  usually partition  into  the  detergent phase, 
whereas those that are water soluble will partition into the aqueous phase (20). 
To  test  whether this  expectation  holds  true  for  class  I  molecules,  a  control 
experiment  was  performed.  The  protease  papain  is  known  to  generate  two 
discrete proteolytic fragments of the heavy chain, a 39,000-D fragment that lacks 
the carboxy terminal hydrophilic tail but retains the hydrophobic region, and a 
35,000-D fragment that lacks both of these segments of the polypeptide (28). In 
Fig. 3 A, increasing amounts of papain were used to convert the 43,000-D cellular 
form  of the  HPB-ALL  class  I  polypeptides  successively to  39,000-  and  then 
35,000-D  forms.  It was found that whereas the 43,000-  and  39,000-D  species 
partitioned into the TX-114 detergent phase, the 35,000-D  species partitioned KRANGEL  1179 
into the aqueous phase.  Thus, as expected,  those fragments that retained  the 
hydrophobic region bound detergent, whereas that that had lost the hydrophobic 
region failed to bind detergent. 
Fig.  3B  shows that the  39,000-D,  supernatant-localized polypeptides fail  to 
bind detergent, since they partition into the TX-114 aqueous phase (lanes 5-8). 
This is also the case for the 39,000-D, cellular polypeptides (lanes I-4), support- 
ing the argument that they are related to, and hence likely represent intracellular 
precursors of, the supernatant forms. These detergent-binding properties con- 
trast sharply with those of the 39,000-D proteolytic fragment of the heavy chain 
(Fig.  3A), indicating that the  39,000-D  supernatant-localized polypeptides are 
not proteolytic fragments of the membrane forms. Separate experiments based 
upon the sedimentation of culture supernatant material through sucrose density 
gradients  indicate  that  the  supernatant-localized  molecules  behave  as  simple 
heavy chain-light chain heterodimers, and thus are not present in any larger 
aggregates (data not shown). Together, these experiments provide evidence that 
the supernatant-localized molecules are water soluble heterodimers, that they do 
not arise from the cellular forms by a simple truncation at the carboxy terminus, 
and that they probably do not contain a  functional hydrophobic region. Thus 
they appear to be truly secreted forms of class I molecules, as distinguished from 
proteolyzed or shed forms. In all of these properties they appear closely related 
to the HLA-A2 molecules secreted by mutant 8.14.1. 
Structural  Analysis  Indicates  an  Internal  Deletion  Near  the  Carboxyl  Termi- 
nus.  More direct information regarding the physical structure of the secreted 
molecules was obtained by proteolytic cleavage analysis of the carboxyl terminus. 
As noted above, proteolysis using the enzyme papain is known to degrade the 
43,000-D heavy chain to a 39,000-D fragment that has lost the carboxy terminal 
hydrophilic tail, and a 35,000-D fragment that has in addition lost the hydropho- 
bic region. As shown in Fig. 4A, these cleavages occur normally for the HPB- 
ALL cellular class I antigens. However, they do not occur normally for the HPB- 
ALL-secreted  class  I  antigens  (Fig.  4B).  In  this  case,  an  initial  cleavage  to 
~38,000 D is observed, which is then followed by a cleavage to a 35,000-D limit 
product. The initial cleavage that removes 1,000 D has been observed previously 
for the membrane form, and is therefore not regarded as a significant departure 
from  the  norm  (5).  However,  the  fact  that  the  limit papain  products  of the 
cellular and secreted forms are of similar size implies that the structural difference 
between the cellular and secreted forms resides somewhere within their carboxy 
termini. It is particularly striking that the cleavage pattern for the HPB-ALL- 
secreted molecule is identical to that observed for the HLA-A2 molecule secreted 
by mutant 8.14.1  (Fig. 4 C). Further analysis using P. fragi protease is presented 
in Fig. 4, D-F. This protease is known to cleave the class I antigen heavy chain 
within the  carboxy  terminal  hydrophilic region,  and  hence should serve as  a 
marker  for  the  presence of this portion  of the  polypeptide (29).  The  results 
clearly map P. fragi protease cleavage sites to identical distances from the carboxy 
termini of the cellular and secreted molecules. Again, the cleavage pattern for 
the HPB-ALL-secreted molecule is identical to that for the HLA-A2 molecule 
secreted by mutant 8.14.1.  The mapping of these proteolytic cleavage sites has 
previously been interpreted as predictive of an internal deletion removing the 1180  SECRETION OF  HUMAN CLASS I  ANTIGENS 
FIGURE 4.  Proteolytic  digestion analysis  of cell lysate and culture supernatant class I poly- 
peptides. HPB-ALL  and 8.14.1 cells were labeled in the presence of [sSS]methionine,  and cell 
lysates and culture supernatants were prepared. Aliquots of HPB-ALL cell lysate (it and D), 
HPB-ALL culture supernatant (B and E), and 8.14.1 culture supernatant (C and F), were 
treated with varying amounts of either papain or P. fragi protease, precisely as described 
previously (5). Immunoprecipitation was performed using W6/32, and immunoprecipitated 
polypeptides were analyzed by SDS-PAGE followed by fluorography. Within each panel, the 
leftmost lane represents a control incubation in the absence of protease. From left to right, 
papain concentrations were 0.1, 1.0, 10.0, and 100.0 #g/ml, and P. fragi protease concentra- 
tions were 11.2, 56.0, 280.0, and 1400.0 #g/ml. 
transmembrane hydrophobic region, rather than a  simple truncation removing 
the carboxy terminal hydrophilic peptide  (5).  Hence these  structural  data are 
consistent with the functional data obtained based upon TX-114 binding. 
Detection of Alternatively Spliced  Transcripts Encoding HLA-A24.  The internal 
deletion suggested by the above data could be explained by an alternative splicing 
model, in which the secreted molecules would derive from transcripts from which 
exon  5  had been  removed,  whereas  the  membrane  forms would derive  from 
transcripts  that retain  this exon.  To  provide  direct evidence for such splicing 
patterns,  two types of experiments were performed.  Both experiments rely on 
the use of a synthetic oligodeoxyribonucleotide (A4/6), which consists of the last 
ten nucleotides of exon 4 juxtaposed with the first ten nucleotides of exon 6, on 
the noncoding strand of the HLA-A2 gene. Previous experiments using mutant 
8.14.1  and its wild-type parent cell line T5-1  have shown that A4/6 can be used 
to probe  Northern  blots  to  selectively detect transcripts  that lack exon  5  (6). 
Further, this oligonucleotide could also be used to detect cDNA clones derived 
from such transcripts.  In Fig. 5, RNA samples isolated from T5-1,  8.14.1, and 
HPB-ALL are resolved by agarose gel electrophoresis, transferred to nitrocel- 
lulose, and probed with either a S~P-labeled cDNA probe which should hybridize 
to all class I antigen encoding transcripts,  or 32P-labeled oligonucleotide A4/6. 
The cDNA probe detects transcripts present in all three cell lines (Fig. 5A). The 
oligonucleotide, however,  detects transcripts present in  8.14.1  and HPB-ALL, 
but  absent  from  T5-1  (Fig.  5B).  The  detection  of these  transcripts  provides KRANGEL  1181 
FIGURE 5.  Northern blot analysis of T5-1, 8.14.1, and HPB-ALL class I transcripts. Poly(A) 
+ RNA isolated from T5-1, 8.14.1, and HPB-ALL was fractionated on a 1.5% agarose gel, 
transferred to nitrocellulose, and hybridized with either the s~P-labeled  HLA-B7 cDNA probe 
(A) or s~P-labeled oligonucleotide A416 (B). The same nitrocellulose filter was used with both 
probes. 
strong evidence that  the proposed splicing pattern  indeed occurs in  the  HPB- 
ALL cell line. 
It  remained  to  be  proven  that  transcripts  encoding a  single  allelic  product 
could be spliced in both fashions, and that the proposed structure of the secreted 
polypeptides  was  fully  consistent  with  the  structure  of the  unusually  spliced 
transcripts. To do so, both oligonucleotide A4]6 and the cDNA probe were used 
in a  double  screen of a  cDNA  library constructed in  the  lambda  gtl0  vector, 
using  RNA  isolated  from the cell  line HPB-MLT (Dialynas,  D.,  C.  Murre,  T. 
Quertermous, j.  M.  Boss, J.  G.  Seidman,  and J.  L.  Strominger,  manuscript 1182 
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250  260 
CT  GTG GTG GTA  CCT  TCT  GGA GAG GAG CAG AC-A TAC ACC TGC  CAT  GTG CAG CAT  GAG GGT 
CT  GTG  GTG  GTA  CCT  TCT  GGA  GAG  GAG  CAG  AGA  TAC  ACC  TGC  CAT  GTG  GAG  CAT  GAG  GGT 
270  E4E5  280 
CTG  CCC  AAG CCC  CTC  ACC  CTG  AGA TGG  GAG C~CA TCT  TCC  CAG CCC  ACC  GTC  CCC  ATC  GTG 
CTG CCC AAG CCC CTC ACC CTG AGA TGG G  ................................ 
290  300 
GGC Arc ATT GCT GGC CTG GTT CTC CTT GGA GCT GTG ATC ACT GGA GCT GTG GTC GCT GCT 
............................................................ 
310  F..SE6  320  E6E7 
GTG ATG TGG AGG AGG AAC AGC TCA GAT AGA AAA GGA GGG AGC TAC TCT CAG GCT GCA AGC 
.........................  AT AGA AAA GGA GGG AGC TAC TCT CAG GCT GCA AGC 
330  340E7E8 
AGT GAC ACT GCC CAG GGC TCT GAT GTG TCT CTC ACA C-CT TGT AAA GTG TGAGACAG 
AGT GAC AGT GCC CAG GGC TCT GAT GTG TCT CTC ACA GCT TGT AAA GTG TGAGACAG 
FIGURE  6.  Partial nucleotide sequences of clones  1 and 5. Sequences are divided into triplet 
codons which are numbered  from the amino terminus of the mature protein. Exon boundaries 
are marked,  i.e., E4E5.  (-)  indicates nucleotides encoded  within exon 5  that are absent from 
clone 1. 
submitted for publication). Although HPB-ALL and HPB-MLT are documented 
to  be of independent origin  (27),  the stocks presently available appear  to  be 
identical. As evidence for this, both cell lines react with the T40/25  clonotypic 
anti-T cell receptor antibody (30), both appear to have undergone identical T 
cell receptor beta chain gene rearrangements (Leiden, J. M., D. P. Dialynas, A. 
D. Duby, C. Murre, J. Seidman and J. L. Strominger, manuscript submitted for 
publication), and both express identical arrays of cellular and secreted class  I 
polypeptides,  as  analyzed  by  two-dimensional  gel  electrophoresis  (data  not 
shown). 
Duplicate filters carrying ~300,000  plaques were screened with each probe. 
Of the ~60 plaques found to hybridize with the cDNA probe, one also hybridized 
with  oligonucleotide  A4/6.  It  is  likely  that  this  represents,  if anything,  an 
underestimate of the relative abundance of unusually spliced transcripts, because 
the  cDNA  probe  would  be  expected  to  hybridize  with  clones derived  from 
unusually spliced  transcripts  that  might  not  be  long  enough  to  include  the 
sequence complementary to  the oligonucleotide. Clone 1,  which was cDNA+ 
and A4/6+, and five randomly selected cDNA+ and A4/6- clones were analyzed 
in detail. Since HPB-ALL secretes primarily its A  locus product, HLA-A24, it 
was deemed likely that clone 1 would represent an HLA-A24-encoding cDNA, 
as would at least some of the randomly selected clones. It has so far been possible 
to distinguish  HLA-A- from HLA-B-encoding cDNAs by the presence of an 
internal 165-bp Pst I fragment in the former (6, 31). Clone 1, along with clones 
5 and 7,  were found to contain such a  fragment. Based upon the sequence of 
the HLA-A24 gene, Pvu II sites would be expected in the middle of exon 4, and 
at the beginning of exon 8 (32).  Thus Pvu II digestion should yield fragments 
of different size, dependent upon the splicing pattern within this region. Whereas 
fragments of 290 bp were generated from clones 5 and 7, a fragment of 165 bp 
was generated from clone  1.  The clone  1 and clone 5  Pvu II fragments were 
then subcloned and their sequences determined. 
Fig.  6  presents the nucleotide sequences of the clone  1 and clone 5  Pvu I! 
fragments. Both clones begin within codon 246 and end a few nucleotides into KRANGEL  1183 
the 3' untranslated region. The sequence of clone 5 is identical to that reported 
for the same region of the HLA-A24 gene (32). The sequence of clone 1 differs 
only in that the  117  nucleotide stretch which derives from exon 5 is precisely 
deleted. Exons 6-8 are retained, and the reading frame is unaltered. The HLA- 
A24 transcript from which this cDNA derives would be expected to encode a 
molecule missing 39 amino acids, including the hydrophobic amino acids which 
would normally function to anchor the polypeptide in the plasma membrane, 
but retaining a normal carboxyl terminus. This agrees precisely with the structure 
proposed for the class  I  polypeptides secreted by HPB-ALL.  These data thus 
provide strong evidence that alternative splicing of HLA-A24 transcripts does 
occur in this cell line, and that the resultant transcripts that lack exon 5 encode 
class I polypeptides that are secreted rather than membrane bound. 
HLA-A and -B Antigens Are Both Secreted and Shed From a Variety of Other Cell 
Lines.  The  generality of these  findings has  been assessed  by extending the 
immunochemical analysis to a  variety of other cell lines. Supernatant-localized 
class I  molecules could be detected in some, but not in all, cases. Certain cells 
displayed a particularly complex pattern of supernatant class I molecules, which 
required more careful analysis. An example of this is the B cell line AS (HLA- 
A2, -A24, -B27), for which data are presented in Figs. 7 and 8. 
Fig. 7 A shows that AS culture supernatants contain three distinct size classes 
of class  I  polypeptides of 43,000,  39,000,  and  35,000  D.  TX-114  extraction 
shows  that  the  43,000-D  form  is  detergent  binding,  while  the  39,000-  and 
35,000-D forms are not (lanes 5-8). Ultracentrifugal flotation analysis was used 
to assess whether any of the species were lipid associated (Fig.  7B).  All three 
species sediment through medium at a density of 1.06 g/ml (lanes 1-3). However, 
whereas the 39,000- and 35,000-D species sediment through medium at a density 
of 1.21  g/ml,  the 43,000-D  species floats (lanes 4-6).  This  indicates that  the 
43,000-D form is lipid associated, whereas the other forms are not. Hence, the 
43,000-D polypeptides appear to be intact class I molecules which are shed from 
cells  in  association  with  membrane lipid.  However,  due  to  both  the  lack  of 
detergent binding, and the absence of lipid association, the 39,000-D  material 
cannot represent a proteolyzed form of the 43,000-D species. As argued previ- 
ously, a  39,000-D  proteolytic fragment of the heavy chain  must  contain  the 
hydrophobic region, and as a result will bind TX-114 (Fig.  3A), and would be 
expected to be lipid associated. Thus the 39,000-D species detected here is likely 
to arise neither by proteolysis nor shedding, but rather by secretion as a result 
of an alternative splicing pathway, as described for HPB-ALL. The origin of the 
35,000-D species is less certain, although it is reasonable to assume that it indeed 
may arise by proteolysis of the larger forms. 
Both  HLA-A and  HLA-B  products are  found as  lipid-associated  43,000-D 
species in AS culture supernatants (data not shown). Two-dimensional gel elec- 
trophoretic analysis of the water soluble fraction of AS culture supernatant is 
presented in Fig.  8.  Whereas HLA-A2, -A24, and -B27 can all be detected in 
the cell lysate (Fig. 8, A-C), only HLA-A24 is present as a water soluble, 39,000- 
D form (Fig. 8, D-F). Hence, at least two distinct processes occur in this cell line: 
nonspecific shedding of lipid-associated molecules, and allele-specific secretion 
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FIGURE 7.  Analysis of class I polypeptides in AS cell lysate and culture supernatant prepa- 
rations. AS cells were labeled for 4 h in the presence of [sSS]methionine, after which culture 
supernatant was harvested, and cell lysates were prepared using either NP-40 or TX-114. (A) 
Polypeptides were immunoprecipitated from aliquots of NP-40  lysate using either normal 
rabbit serum (lane 1) or W6/32 (lane 2). An equivalent aliquot of TX-114 lysate was separated 
into aqueous (lane 3) and detergent phases (lane 4), which were then used for immunoprecip- 
itation with W6/32. Polypeptides were immunoprecipitated from aliquots of culture superna- 
tant using either normal rabbit serum (lane 5) or W6/32 (lane 6). TX-I 14 was added to an 
equivalent aliquot of  supernatant, which was then separated into aqueous (lane 7) and detergent 
(lane 8) phases. Immunoprecipitation was then performed using W6/32. Aliquots of cell lysate 
represent 0.1  times the cell equivalents used for culture supernatant immunoprecipitations. 
(B)  AS culture  supernatant  was  brought  to  either  1.06  g/ml  or  1.21 g/ml,  after which 
ultracentrifugal flotation analysis was performed. Lanes 1-3 show the polypeptides immuno- 
precipitated from the upper, middle, and lower portions of the tube, respectively, following 
centrifugation at 1.06  g/ml. Lanes 4-6 show the polypeptides immunoprecipitated from the 
upper, middle, and lower portions of the tube, respectively, after centrifugation at 1.21 g/ml. 
Lane 7 displays the polypeptides immunoprecipitated from the culture supernatant before 
centrifugation. Immunoprecipitation was using W6/32, and analysis was by SDS-PAGE fol- 
lowed by fluorography. 
This  analysis  was  then  extended  to  a  panel  of other  cell  lines.  Secretion  of 
water  soluble,  39,000-D  class I  molecules was  a  property  of some,  but  not  all, 
cell lines.  No  cell line tested  was  found  to express levels as high  as  HPB-ALL. 
Levels  for  some  positive  cell  lines  were  as  high  as  1%,  and  for  others  were 
between  0.1  and  1%.  If presumed  intracellular precursors  are  included  in  the 
analysis, these  levels would  be  doubled  or  tripled  in  most  cases.  These  levels 
were independent  of cell type, but seemed to vary, dependent  upon  HLA  type. 
Specifically, the cell lines found  to secrete at higher  levels were typed as either KRANGEL  1185 
FIGURE 8.  Two-dimensional  gel electrophoresis of immunoprecipitates  from AS cell lysate 
and culture supernatant aqueous phase. AS cells were labeled for 4 h in the presence of 
[35S]methionine, after which cell lysate  and culture supernatant  were prepared. TX-114 was 
added to the culture supernatant, and the aqueous phase was used. Immunoprecipitation  was 
with: W6/32 (HLA-A-, -B-, -C-specific),  A and D; PA2.1 (HLA-A2-specific),  B and E; and 
4E (HLA-B-, -C-specific), C and F. Those spots immunoprecipitated  by W6/32, but not 
immunoprecipitated  by either PA2.1 or 4E are presumed to represent HLA-A24. Cell lysate 
immunoprecipitations  were from 0.1 times the cell equivalents used for culture supernatant 
immunoprecipitations. 
HLA-A24 or HLA-A9. These cell lines included the T cell line HPB-ALL (HLA- 
A24, -BwS1),  the B cell lines AS (HLA-A2, -A24, -B27) and WT51  (HLA-Ag, 
-B 14), and the hepatoma cell line HEP-G2 (HLA-A2, -A9, -B5, -Bw 17; reference 
33).  Based upon two-dimensional gel electrophoretic analysis, HLA-A9 or -A24 
was the only allele secreted from AS and HEP-G2, and was the primary allele 
secreted from HPB-ALL and WT51. In fact, HLA-A24, along with HLA-A23, 
are recent splits of the broader HLA-A9 specificity, and thus all of these cell 
lines may secrete a related, if not identical, allelic product. Cell lines expressing 
intermediate levels of secreted class I molecules included the T  cell lines Molt-3 
(HLA-A  1, -A 10), 8402 (HLA-A  1, -A29), and HSB (HLA-A  1, -A2, -B 12, -Bw 17), 
as well as the B cell line SB (HLA-A 1, -A2, -B12, -Bwl 7).  Secretion was either 
extremely low  or  undetectable for the  B  cell  lines  MST  (HLA-A3, -B7),  JY 
(HLA-A2,-B7), 23.1  (HLA-A2, -B27), and TS-1 (HLA-A1, -A2,-B8, -B27). 
HLA-A and -B Antigens Are Secreted  by Normal PBL.  Mitogen-activated PBL 
were examined for class I antigen secretion as well. Results for cells derived from 
three  different donors,  M.B.  (HLA-A1,  -A24,  -B18,  -Bw44), J.C.  (HLA-A2, 
-A23,  -B27,  -Bw44),  and  M.L. (HLA-A2, -A11,  -B7,  -Bw$5)  are presented in 
Fig. 9, A, B, and C, respectively. In each case, 39,000-D class I polypeptides that 
partition into the TX-114  aqueous phase  could be detected. At lower levels, 
43,000-D polypeptides that partition into the TX-114 detergent phase could be 
detected as well. Levels of secreted, 39,000-D polypeptides were -1% for M.B. 
and J.C.  cells,  but  were  lower for M.L.  Two-dimensional gel  electrophoretic 
analysis indicated that M.B. cells primarily secrete an HLA-A locus product, J.C. 1186  SECRETION  OF  HUMAN  CLASS  I  ANTIGENS 
FIGURE 9.  Analysis of class I polypeptides in PBL cell lysate and culture supernatant prepa- 
rations.  PHA-stimulated PBL were labeled for 4  h  in the presence of [sSS]methionine, after 
which culture supernatants  (SN) were harvested, and detergent lysates (cells) prepared.  TX- 
114 was added to culture supernatant  preparations,  which were then separated into aqueous 
(A) and detergent (D) phases.  Immunoprecipitation was then performed using either normal 
rabbit serum (lanes 1, 3, and 5) or W6/32 (lanes 2, 4, and 6). Peripheral blood cells were from 
donors M.B. (A),J.C. (B), and M.L. (C). Cell lysate immunoprecipitations were from 0.1 times 
the cell equivalents used for culture supernatant immunoprecipitations. Analysis was by SDS- 
PAGE followed by fluorography. 
cells primarily secrete an HLA-B locus product, and M.L. cells secrete HLA-A 
and -B locus products at comparable levels (data not shown). Thus secretion has 
been detected in both tumor cells and normal cells, and at the present level of 
analysis, occurs consistently, but not exclusively, for HLA-A24, and independent 
of cell type. 
Discussion 
Previous work has identified a mutant of the B lymphoblastoid cell line T5-1, 
called 8.14.1, which secretes a water soluble form of the HLA-A2 antigen (4, 5). 
Characterization  of the secreted polypeptide indicated that it carries an internal 
deletion near the carboxyl terminus, including the hydrophobic amino acids that 
would normally function to anchor the polypeptide in the plasma membrane.  It 
was proposed  that  this  structure  could  result  from  an  unusual  RNA  splicing 
event,  which  deletes  exon  5  from  HLA-A2-encoding  transcripts.  This  was 
confirmed  by  the  demonstration,  by both  Northern  blot  analysis  and  cDNA 
cloning, that transcripts  precisely deleted for the  117 nucleotide stretch known 
to be encoded by exon 5 were present in the mutant, but not the parent cell line 
(6).  Using these cell lines as a  model system, a variety of approaches have been KRANGEL  1187 
developed, both at the protein and nucleic acid level, to assess whether a similar 
phenomenon occurs in nonmutagenized cells. The present work documents: (a) 
the secretion of class I  molecules (primarily HLA-A24) by the T  leukemic cell 
line  HPB-ALL  that  have properties indistinguishable  from those secreted by 
mutant 8.14.1;  (b) alternative splicing that removes exon 5 from a  fraction of 
HLA-A24-encoding  transcripts;  and  (c)  the  secretion,  possibly  in  an  allele- 
specific fashion, of class I antigens from a variety of tumor cells and normal cells. 
This  represents the first demonstration of bona  fide,  water soluble,  secreted 
HLA antigens in nonmutagenized cells, and similarly the first demonstration of 
naturally occurring alternative splicing in  the HLA system. It is not formally 
proven that in the case of HPB-ALL the unusually spliced HLA-A24 transcripts 
actually encode the HLA-A24 molecules secreted by this cell line. However the 
close correlation between the deduced structure and properties of the secreted 
molecules and the structure of the unusually spliced transcripts argues persua- 
sively that this is so. This correlation is strengthened by the example of mutant 
8.14.1, since it is distinguishable from the parent cell line by both the secretion 
of HLA-A2 and the unusual splicing of HLA-A2-encoding transcripts (5, 6). 
Alternative splicing has been shown in a number of instances for murine class 
I  antigens.  Thus,  it  has  been  shown  that  the H-2K d gene gives  rise  to  two 
transcripts that differ in the pattern of splicing at the 5' end of exon 2 (34), and 
the QIO gene gives rise to transcripts that either include or exclude exon 3 (35). 
H-2Dd-encoding cDNAs have been obtained that either include or exclude exon 
7 (36), and H-2Kq-encoding cDNAs have been obtained that result from the use 
of either an upstream or a downstream splice acceptor site at the 5' end of exon 
8  (37).  In those cases for which quantitative information is available,  the non- 
standard splicing pattern appears to occur at a level ~5-10% that of the standard 
pattern (34, 35). Since the discovery of these splicing patterns has relied on the 
sequence analysis of a  limited number of cDNA clones, it is very possible that 
other patterns of splicing may have gone undetected. That alternative splicing 
has not heretofore been documented for the HLA system is probably due to the 
more extensive analysis of murine cDNA clones to date. Whether these splicing 
patterns contribute to the functional heterogeneity of class I polypeptides remains 
to be determined. Unlike in some other systems, there is as yet no evidence for 
the regulation and/or tissue specificity of splicing.  However, the total level of 
heterogeneity of class I antigen transcripts may be too high to attribute to mere 
sloppiness in the system. 
Although soluble and/or serum forms of class I molecules have been reported 
previously,  the  mechanism described here is  distinct.  A  nonpolymorphic  Qa 
region gene, QIO, encodes a liver-specific, secreted class I polypeptide, which is 
detectable in murine serum (9-12). This molecule is apparently secreted because 
QIO exon  5  contains numerous substitutions,  a  frameshift, and a  termination 
codon,  resulting  in  the  synthesis  of a  truncated  polypeptide  lacking  a  true 
hydrophobic region. Similarly, it has been proposed that another gene within 
the Qa region, 27.1, might encode a secreted polypeptide, because it too carries 
a termination codon within exon 5 (35). On the other hand, Emerson et al. have 
shown that the products of the classical transplantation loci are shed, in associa- 
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labeled murine spleen cells (8). Intriguingly, this could be shown for H-2K  k, but 
not H-2D  k.  This shedding process may be related  to that  which generates  the 
lipid-associated, 43,000-D class I polypeptides found in culture supernatants  of 
some of the cell lines examined here, including AS. However, no evidence has 
been accumulated to suggest any allelic specificity in the cell lines examined. 
Using  aUoantisera,  and  more recently mAbs,  it  has  been possible to  detect 
HLA-A and -B specificities in 100,000 g supernatants of human serum (reviewed 
in reference 7). The precise structure and origin of these molecules is unclear. 
However,  it  appears  that  different  allelic  products  are  present  in  serum  at 
reproducible and  characteristic  levels. Notably, HLA-A9 has been reported to 
be present at levels significantly higher than any other allele tested (7, 38). This 
is particularly striking  in view of the results reported here, since HLA-A9 and 
HLA-A24  (a  recent  serological  split  of the  HLA-A9  specificity) appear  to  be 
secreted in  water soluble form at  levels higher  than  the product of any other 
allele examined. Paradoxically, the HLA-A9 in human serum has been reported 
to  be  lipoprotein-like,  based  upon  ultracentrifugal  flotation  under  conditions 
identical to those used in this report (21). Whether these disparate observations 
can be reconciled awaits further analysis. 
Our present  understanding  of the function of class I  molecules is limited to 
the cell surface forms of the products of the classical transplantation  loci. In this 
form  they  appear  to  mediate  interactions  between  CTL  and  virally  infected 
target cells. However, functions have yet to be ascribed to even the cell surface 
forms of the  Qa and  Tla  region  gene  products.  There  is at  present  no good 
conceptual framework that accommodates the presence of soluble forms of any 
class I molecule. However it now appears that a number of distinct forms of such 
molecules clearly exist. Whether they serve an important functional role, or are 
in any other way of physiological consequence, remains to be determined. 
Summary 
Human  class  I  major  histocompatibility  antigens  (HLA-A,  -B  and  -C)  are 
integral membrane protein heterodimers, which are anchored in the membrane 
via a stretch of hydrophobic amino acids near the carboxyl terminus of the heavy 
chain.  It has previously been shown that a mutagenized cell line secretes a water 
soluble form  of the  HLA-A2  antigen,  due  to a  pattern  of RNA splicing that 
removes exon 5 (encoding the transmembrane  hydrophobic amino acids) from 
mature,  HLA-A2-encoding transcripts.  The  present  study was undertaken  to 
assess whether a similar process might be operative in nonmutagenized  cells. It 
is shown that water soluble class I molecules (primarily HLA-A24) are secreted 
by the T  leukemic cell line HPB-ALL, and that alternative splicing removes exon 
5  from a  fraction  of HLA-A24-encoding  transcripts.  It is further  shown  that 
class I molecules are secreted, possibly in an allele-specific fashion, from a variety 
of tumor cells and normal cells. The possible relationship between these findings 
and previous reports of HLA-A and -B antigens in human serum is discussed. 
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would  also  like  to  thank John  Fraser  and  Mike  Brenner  for  their  comments on  the 
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